JPMorgan Chase & Co’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.13M | Sell |
193,850
-290,947
| -60% | -$9.19M | ﹤0.01% | 2553 |
|
|
2025
Q1 | $16.1M | Buy |
484,797
+248,915
| +106% | +$8.26M | ﹤0.01% | 1832 |
|
|
2024
Q4 | $8.12M | Buy |
235,882
+5,454
| +2% | +$188K | ﹤0.01% | 2399 |
|
|
2024
Q3 | $9.22M | Buy |
230,428
+93,622
| +68% | +$3.74M | ﹤0.01% | 2215 |
|
|
2024
Q2 | $4.13M | Buy |
136,806
+93,967
| +219% | +$2.83M | ﹤0.01% | 2635 |
|
|
2024
Q1 | $1.44M | Sell |
42,839
-80,065
| -65% | -$2.69M | ﹤0.01% | 3350 |
|
|
2023
Q4 | $3.97M | Buy |
122,904
+44,036
| +56% | +$1.42M | ﹤0.01% | 2705 |
|
|
2023
Q3 | $2.58M | Sell |
78,868
-24,240
| -24% | -$794K | ﹤0.01% | 2854 |
|
|
2023
Q2 | $3.63M | Buy |
103,108
+48,914
| +90% | +$1.72M | ﹤0.01% | 2698 |
|
|
2023
Q1 | $1.77M | Sell |
54,194
-38,611
| -42% | -$1.26M | ﹤0.01% | 3108 |
|
|
2022
Q4 | $5.11M | Sell |
92,805
-23,480
| -20% | -$1.29M | ﹤0.01% | 2355 |
|
|
2022
Q3 | $5.15M | Buy |
116,285
+19,322
| +20% | +$856K | ﹤0.01% | 2320 |
|
|
2022
Q2 | $4.73M | Buy |
96,963
+71,620
| +283% | +$3.49M | ﹤0.01% | 2432 |
|
|
2022
Q1 | $1.23M | Buy |
25,343
+3,017
| +14% | +$147K | ﹤0.01% | 3488 |
|
|
2021
Q4 | $953K | Buy |
22,326
+12,806
| +135% | +$547K | ﹤0.01% | 3716 |
|
|
2021
Q3 | $365K | Sell |
9,520
-617
| -6% | -$23.7K | ﹤0.01% | 4120 |
|
|
2021
Q2 | $285K | Sell |
10,137
-6,985
| -41% | -$196K | ﹤0.01% | 4309 |
|
|
2021
Q1 | $565K | Sell |
17,122
-2,366
| -12% | -$78.1K | ﹤0.01% | 3977 |
|
|
2020
Q4 | $704K | Buy |
19,488
+19,102
| +4,949% | +$690K | ﹤0.01% | 3564 |
|
|
2020
Q3 | $12K | Buy |
+386
| New | +$12K | ﹤0.01% | 4572 |
|